Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Luminari

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2022
Reply to M. Shibusawa et alStefano Luminari, Luca Arcaini, Massimo Federico
Cancer Journal (Sudbury, Mass.)|June 5, 2020
Advances in Treatment of Follicular LymphomaStefano Luminari, Judith Trotman, Massimo Federico
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
Reply to T.P. Vassilakopoulos et alFrancesco Merli, Massimo Federico, Stefano Luminari
Leukemia & Lymphoma|January 11, 2024
Curative intent therapy for DLBCL in the elderlyAlessandra Tucci, Lorenzo Masina, Stefano Luminari
Leukemia & Lymphoma|October 15, 2025
The emerging role of tafasitamab in follicular lymphomaTanja Lazic, Emiliano Barbieri, Stefano Luminari
Hematology Reports|May 16, 2012
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphomaStefano Luminari, Antonella Montanini, Massimo Federico
British Journal of Haematology|March 13, 2021
The use of frailty assessments in treating older adults with aggressive lymphomasRaul Cordoba, Stefano Luminari, Toby A Eyre
British Journal of Haematology|August 30, 2025
Towards a chemo-free approach for follicular lymphomaStefano Luminari, Emiliano Barbieri, Maria Elena Nizzoli
Best Practice & Research. Clinical Haematology|March 29, 2005
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) groupAndrew M Evens, Charles L Bennett, Stefano Luminari
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in low-grade non-Hodgkin lymphomasMassimo Federico, Stefano Molica, Monica Bellei, et al.
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2022
Reply to M. Shibusawa et alStefano Luminari, Luca Arcaini, Massimo Federico
Cancer Journal (Sudbury, Mass.)|June 5, 2020
Advances in Treatment of Follicular LymphomaStefano Luminari, Judith Trotman, Massimo Federico
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
Reply to T.P. Vassilakopoulos et alFrancesco Merli, Massimo Federico, Stefano Luminari
Leukemia & Lymphoma|January 11, 2024
Curative intent therapy for DLBCL in the elderlyAlessandra Tucci, Lorenzo Masina, Stefano Luminari
Leukemia & Lymphoma|October 15, 2025
The emerging role of tafasitamab in follicular lymphomaTanja Lazic, Emiliano Barbieri, Stefano Luminari
Hematology Reports|May 16, 2012
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphomaStefano Luminari, Antonella Montanini, Massimo Federico
British Journal of Haematology|March 13, 2021
The use of frailty assessments in treating older adults with aggressive lymphomasRaul Cordoba, Stefano Luminari, Toby A Eyre
British Journal of Haematology|August 30, 2025
Towards a chemo-free approach for follicular lymphomaStefano Luminari, Emiliano Barbieri, Maria Elena Nizzoli
Best Practice & Research. Clinical Haematology|March 29, 2005
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) groupAndrew M Evens, Charles L Bennett, Stefano Luminari
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in low-grade non-Hodgkin lymphomasMassimo Federico, Stefano Molica, Monica Bellei, et al.
Pageof 21